BioXcel Therapeutics, Inc. (NASDAQ:BTAI) Q1 2024 Earnings Call Transcript insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.
BioXcel Therapeutics Hosting Virtual Neuroscience R&D Day Today tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Operator: Good morning, and welcome to the BioXcel Therapeutics Conference Call, which will cover its alignment with the FDA on its TRANQUILITY program, provide an update on strategic financing, and review.
BioXcel Therapeutics, Inc. (NASDAQ:BTAI – Get Rating) saw a significant increase in short interest in March. As of March 31st, there was short interest totalling 3,600,000 shares, an increase of 21.2% from the March 15th total of 2,970,000 shares. Currently, 18.3% of the shares of the company are sold short. Based on an average trading […]
Should You Buy or Sell BioXcel Therapeutics Stock? Get The Latest BTAI Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat.